DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,504 filers reported holding DANAHER CORPORATION in Q4 2019. The put-call ratio across all filers is 1.66 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $509,289 | -16.1% | 2,420 | -4.3% | 0.20% | -15.3% |
Q2 2023 | $607,200 | -6.3% | 2,530 | -1.6% | 0.24% | -11.7% |
Q1 2023 | $647,995 | -5.0% | 2,571 | 0.0% | 0.27% | -9.5% |
Q4 2022 | $682,395 | +5.5% | 2,571 | 0.0% | 0.29% | +2.8% |
Q3 2022 | $647,000 | -0.8% | 2,571 | 0.0% | 0.29% | -3.4% |
Q2 2022 | $652,000 | -26.4% | 2,571 | -4.5% | 0.30% | -12.4% |
Q4 2021 | $886,000 | +7.9% | 2,692 | -0.2% | 0.34% | -2.6% |
Q3 2021 | $821,000 | +15.5% | 2,697 | +1.8% | 0.35% | +14.1% |
Q2 2021 | $711,000 | +15.2% | 2,649 | +1.9% | 0.30% | +9.7% |
Q1 2021 | $617,000 | -1.0% | 2,599 | +1.6% | 0.28% | -10.9% |
Q4 2020 | $623,000 | +13.1% | 2,559 | 0.0% | 0.31% | -0.6% |
Q3 2020 | $551,000 | +24.7% | 2,559 | +2.4% | 0.31% | +15.9% |
Q2 2020 | $442,000 | +52.9% | 2,499 | +17.9% | 0.27% | +22.7% |
Q1 2020 | $289,000 | -11.1% | 2,119 | +1.0% | 0.22% | +11.1% |
Q4 2019 | $325,000 | +11.7% | 2,099 | 0.0% | 0.20% | +2.1% |
Q3 2019 | $291,000 | -5.5% | 2,099 | -1.6% | 0.19% | -9.8% |
Q2 2019 | $308,000 | +7.7% | 2,133 | -1.7% | 0.22% | +0.5% |
Q1 2019 | $286,000 | +27.7% | 2,170 | 0.0% | 0.21% | -10.1% |
Q4 2018 | $224,000 | -5.1% | 2,170 | 0.0% | 0.24% | +12.3% |
Q3 2018 | $236,000 | +5.8% | 2,170 | 0.0% | 0.21% | +2.9% |
Q2 2018 | $223,000 | +3.2% | 2,170 | 0.0% | 0.21% | -1.4% |
Q1 2018 | $216,000 | +4.9% | 2,170 | +6.1% | 0.21% | +10.0% |
Q4 2017 | $206,000 | – | 2,045 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |